Tagged with GI

pharma Ozgur Tomruk, J&J’s Managing Director for Global Surgery talks about Turkey’s importance for the company, the priorities they have set, J&J’s commitment to quality and his ambition for the company’s future in Turkey. As an introduction for our readers, Ozgur, can you please give an overview of where J&J Turkey…

pharma Nil Tunaşar, managing partner of Transorient, discusses significance of tracking performance metrics among 3PL providers, the organization’s technology overhaul, and also highlights the type of logistics solutions encompassed under Transorient’s Life Sciences and Biopharma line of business. As an introduction for our readers, Nil, please provide some insight into Transorient’s…

Pharma Rolando Medina, managing director for FedEx Puerto Rico and the Caribbean, highlights the logistics provider’s strong commitment to Puerto Rico’s life science industry through a variety of services and flexible delivery options. You have worked in FedEx for many years. What drove you to the company and what defines your…

Pharma John Fernández van Cleve, Chancellor of UPRM, highlights the institution’s strong expertise in engineering and its application in the pharmaceutical and medical device fields. What are some of UPRM’s main assets? We are very blessed to have the best students in Puerto Rico. UPRM’s admission index is the highest on…

Pharma The chairman of PHARMISA reveals how pharmaceuticals has been designated as one of eight priority sectors of South African Government’s Industrial Policy Action Plan (IPAP), how South African life expectancy has increased by around eight years over the last decade, placing further strain on the public healthcare system, and why…

Pharma The CEO of Pierre Fabre for South Africa reveals how his focus has been on marketing the company brand locally, why the goal of the company is to develop business in English speaking Africa, with South Africa acting as the hub, and talks about the Pierre Fabre Foundation, a government-recognized…

Pharma The managing director of UTi Pharma reveals how UTi is no longer just an international forwarding company but covers a broad spectrum of activities; why as global business increases it is only natural that the relative importance of South Africa diminishes; and why as the National Health Initiative develops there…

Pharma The MD of Triclinium Clinical Development discusses how South Africa’s established First and Third World research opportunities and long-established GCP culture have made it a uniquely attractive country for clinical trials; how Triclinium has grown during a challenging decade, emerging as the largest independent home-bred CRO, winning significant preferred provider…

Algeria

Algeria

Pharma The Chairman & CEO of DBV Technologies reveals how they have developed a new therapeutic method and new technology in the form of a patch to treat various allergies. DBV received a “breakthrough” designation from the FDA for the design which meets safety standards that no other products currently being developed do.…

pharmaceuticals Dr Martin Favle, Chairman of Bogin – the Dutch Generic Medicine Industry Association, representing the interests of the generic medicines industry in the Netherlands – shares his fears about slow growth in the Dutch generics market and the state of the biosimilars market. You were quoted in the media last year saying ‘2014 was a…